RedHill Biopharma's total assets for Q2 2023 were $35.04M, a decrease of -40.45% from the previous quarter. RDHL total liabilities were $31.57M for the fiscal quarter, a -44.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.